| scholarly article | Q13442814 |
| P2093 | author name string | Lei Zhang | |
| Ling Li | |||
| Xin Li | |||
| Meng Cui | |||
| Yu Chang | |||
| Mingzhi Zhang | |||
| Jingjing Wu | |||
| Xudong Zhang | |||
| Xiaorui Fu | |||
| Jiaqin Yan | |||
| Zhaoming Li | |||
| Zhenchang Sun | |||
| Feifei Nan | |||
| P2860 | cites work | BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer | Q24273430 |
| Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex | Q24291944 | ||
| TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival | Q24627319 | ||
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. | Q27340206 | ||
| Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines | Q28275084 | ||
| Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer | Q28277781 | ||
| Specific patterns of gene methylation in natural killer cell lymphomas : p73 is consistently involved | Q28344797 | ||
| The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation | Q30659086 | ||
| The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression | Q40837411 | ||
| A role for BRG1 in the regulation of genes required for development of the lymphatic system | Q41550122 | ||
| The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation | Q42008283 | ||
| BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. | Q42488147 | ||
| Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells | Q42827073 | ||
| Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b | Q43141227 | ||
| Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers | Q45862369 | ||
| Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation | Q50157930 | ||
| The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer | Q50640303 | ||
| Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast | Q51504808 | ||
| Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth | Q56825474 | ||
| Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis | Q57382204 | ||
| Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis | Q57754503 | ||
| BAF53 interacts with p53 and functions in p53-mediated p21-gene transcription | Q81316903 | ||
| Non-nasal natural killer cell lymphoma: not non-nasal after all | Q81737130 | ||
| An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis | Q30882732 | ||
| MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing | Q31080906 | ||
| Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project | Q33382121 | ||
| Role of the LXCXE binding site in Rb function | Q33965546 | ||
| LYVE-1, the lymphatic system and tumor lymphangiogenesis | Q34264021 | ||
| BRG-1 is required for RB-mediated cell cycle arrest | Q34509523 | ||
| BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization. | Q34518491 | ||
| BRG1 is a prognostic marker and potential therapeutic target in human breast cancer | Q34637961 | ||
| BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. | Q35545332 | ||
| BRG1 mutations found in human cancer cell lines inactivate Rb‐mediated cell‐cycle arrest | Q35612861 | ||
| Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma | Q35859357 | ||
| Lymphangiogenesis and Cancer | Q36137692 | ||
| Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type | Q36232164 | ||
| The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development | Q36371584 | ||
| The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma | Q36384268 | ||
| Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers | Q36481551 | ||
| Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project | Q37304125 | ||
| BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer | Q37392753 | ||
| The SWI/SNF complex and cancer | Q37398568 | ||
| MicroRNAs in cancer: small molecules with a huge impact | Q37474280 | ||
| MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma | Q37619830 | ||
| The multiple roles of microRNA-155 in oncogenesis | Q38145349 | ||
| Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia | Q38351879 | ||
| Involvement of MicroRNA in T-Cell Differentiation and Malignancy | Q38388753 | ||
| BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines | Q38714250 | ||
| miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr/lpr Mice | Q38882448 | ||
| Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma | Q38917500 | ||
| Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells. | Q38960149 | ||
| Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis. | Q39165264 | ||
| The diagnosis and management of NK/T-cell lymphomas. | Q39243241 | ||
| Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma | Q39329997 | ||
| Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses | Q39521104 | ||
| Role for BRG1 in cell cycle control and tumor suppression | Q40376914 | ||
| Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor | Q40390356 | ||
| Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma | Q40717160 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphangiogenesis | Q6708231 |
| P304 | page(s) | 31-41 | |
| P577 | publication date | 2018-10-09 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1 | |
| P478 | volume | 20 |
| Q93009692 | Effect of gga-miR-155 on cell proliferation, apoptosis and invasion of Marek's disease virus (MDV) transformed cell line MSB1 by targeting RORA |
| Q64085662 | Molecular pathogenic pathways in extranodal NK/T cell lymphoma |
| Q90249920 | miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy |
Search more.